Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT01169168
Brief Summary:
In this study patients with
1. chronicle liver diseases
* primary biliary cirrhosis
* primary sclerosing cholangitis
* alcoholic liver cirrhosis
* hepatitis b or C
* Wilson's disease
* cryptogenic cirrhosis
2. Septic Inflammatory Response Syndrome (SIRS)
* sepsis
* septic shock
3. patients after lysis
should be included
Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods.
The methods are:
* Clauss fibrinogen
* PT-Derived fibrinogen
* immunoturbidimetric method
* heat-precipitated fibrinogen
* Schulz fibrinogen
The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.
Study:
NCT01169168
Study Brief:
Protocol Section:
NCT01169168